lmt-28 and Diabetes-Mellitus--Type-2

lmt-28 has been researched along with Diabetes-Mellitus--Type-2* in 1 studies

Other Studies

1 other study(ies) available for lmt-28 and Diabetes-Mellitus--Type-2

Article	Year
A GP130-Targeting Small Molecule, LMT-28, Reduces LPS-Induced Bone Resorption around Implants in Diabetic Models by Inhibiting IL-6/GP130/JAK2/STAT3 Signaling. Mediators of inflammation, 2023, Volume: 2023 Topics: Animals; Bone Resorption; Cytokine Receptor gp130; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glycation End Products, Advanced; Interleukin-6; Janus Kinase 2; Lipopolysaccharides; Osteoclasts; Peri-Implantitis; RANK Ligand; Rats; Signal Transduction; X-Ray Microtomography	2023

Article

Year

A GP130-Targeting Small Molecule, LMT-28, Reduces LPS-Induced Bone Resorption around Implants in Diabetic Models by Inhibiting IL-6/GP130/JAK2/STAT3 Signaling.

Mediators of inflammation, 2023, Volume: 2023

Topics: Animals; Bone Resorption; Cytokine Receptor gp130; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glycation End Products, Advanced; Interleukin-6; Janus Kinase 2; Lipopolysaccharides; Osteoclasts; Peri-Implantitis; RANK Ligand; Rats; Signal Transduction; X-Ray Microtomography

2023